Clinical Trials
16
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing
- Conditions
- Prostate Cancer
- First Posted Date
- 2020-05-28
- Last Posted Date
- 2025-01-15
- Lead Sponsor
- Myriad Genetic Laboratories, Inc.
- Target Recruit Count
- 500
- Registration Number
- NCT04404894
- Locations
- 🇺🇸
Urology Centers of Alabama, Homewood, Alabama, United States
🇺🇸VA Long Beach Healthcare System, Long Beach, California, United States
🇺🇸Manatee Medical Research Institute, Bradenton, Florida, United States
EndoPredict® Extended Endocrine Trial (EXET)
- Conditions
- Primary Invasive Breast Cancer
- First Posted Date
- 2019-07-12
- Last Posted Date
- 2022-05-17
- Lead Sponsor
- Myriad Genetic Laboratories, Inc.
- Target Recruit Count
- 855
- Registration Number
- NCT04016935
- Locations
- 🇺🇸
Providence, Burbank, California, United States
🇺🇸Sutter Hematology and Oncology, Roseville, California, United States
🇺🇸Florida Cancer Specialists, West Palm Beach, Florida, United States
A Registry for Hereditary Cancer Risk Assessment and Genetic Testing
- Conditions
- Prostate Cancer
- First Posted Date
- 2019-07-10
- Last Posted Date
- 2020-11-05
- Lead Sponsor
- Myriad Genetic Laboratories, Inc.
- Target Recruit Count
- 255
- Registration Number
- NCT04015102
- Locations
- 🇺🇸
Arkansas Urology, Little Rock, Arkansas, United States
🇺🇸Urology Associates of Central California, Fresno, California, United States
🇺🇸Urologic Specialists of Northwest Indiana, Merrillville, Indiana, United States
Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using Prolaris® Testing
- Conditions
- Prostate Cancer
- First Posted Date
- 2018-04-27
- Last Posted Date
- 2020-10-06
- Lead Sponsor
- Myriad Genetic Laboratories, Inc.
- Target Recruit Count
- 774
- Registration Number
- NCT03511235
- Locations
- 🇺🇸
Arkansas Urology, Little Rock, Arkansas, United States
🇺🇸Pacific Urology, Concord, California, United States
🇺🇸Kar Urology, Orange, California, United States
Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate Cancer
- Conditions
- Prostate Cancer
- First Posted Date
- 2017-09-25
- Last Posted Date
- 2022-06-23
- Lead Sponsor
- Myriad Genetic Laboratories, Inc.
- Target Recruit Count
- 524
- Registration Number
- NCT03290508
- Locations
- 🇺🇸
Urology Centers of Alabama, Homewood, Alabama, United States
🇺🇸East Valley Urology Center, Mesa, Arizona, United States
🇺🇸University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
- Prev
- 1
- 2
- 3
- 4
- Next